Josef El Andari, PhD

Dr. Josef El Andari holds a Ph.D. in molecular biology, where his early research centered on the genetics of microorganisms—driven by a deep fascination with how small genetic elements shape complex biological systems. Following his doctoral studies, he pursued postdoctoral studies at Heidelberg University, where he specialized in gene delivery. He became an expert in the engineering of adeno-associated virus (AAV) vectors, with a particular focus on enhancing tissue specificity and transduction efficiency. Building on this expertise, Josef transitioned to DiNAQOR, where he took on successive key roles as Senior Scientist and later Vice President of Genomic Medicine. In this role, he played a central part in shaping the company’s therapeutic pipelines and in developing next-generation delivery platform—integrating medical devices with precise payload delivery systems. His translational research spans multiple disease areas, most notably rare neuromuscular disorders such as Duchenne muscular dystrophy and Pompe disease, alongside a growing interest in the biology of aging and tumor evolution. Throughout his career, Josef has consistently worked at the interface of discovery science and clinical application, advancing technologies that aim to make genetic medicine safer, more efficient, and organ-specific.